Dr. Grossman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 North Broadway Street
Viragh BLDG 5th FL
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1979 - 1981
- University of RochesterResidency, Internal Medicine, 1973 - 1976
- University of Rochester School of Medicine and DentistryClass of 1973
Certifications & Licensure
- MD State Medical License 1979 - 2026
- VA State Medical License 2023 - 2026
- PA State Medical License 2020 - 2022
- WI State Medical License 1976 - 1978
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- America's Top Doctors for Cancer Castle Connolly, 2006-2013
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Procarbazine in Treating Patients With Recurrent Brain Tumor Start of enrollment: 1999 Jul 01
- Karenitecin in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 2002 Jan 01
- Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Leptomeningeal metastatic disease: new frontiers and future directions.Ahmad Ozair, Hannah Wilding, Debarati Bhanja, Nicholas Mikolajewicz, Michael Glantz
Nature Reviews. Clinical Oncology. 2024-12-09 - Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma.Danielle A Bazer, Antonio C Wolff, Stuart A Grossman
Neuro-Oncology. 2024-11-13 - Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.Matthias Holdhoff, Xiaobu Ye, Roy E Strowd, Burt Nabors, Tobias Walbert
Neuro-Oncology Advances. 2024-08-28
Journal Articles
- The Role of Temozolomide in Patients with Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 PandemicStuart Grossman, MD, JAMA Oncology
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/stuart-grossman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: